EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between Symptoms of Depression and Generalised Anxiety Disorder Evaluated through PHQ-9 and GAD-7 and Anti-Obesity Treatment in Polish Adult Women

Tomasz Witaszek iD, Karolina Kłoda iD, Agnieszka Mastalerz-Migas, Mateusz Babicki iD

Nutrients · 2024

DOI: 10.3390/nu16152438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Tomasz Witaszek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tomasz Witaszek-Gabinet Leczenia Otyłości, ul. Józefińska 33/8, 30-529 Kraków, Poland. Hauptthemen laut MEDLINE: Obesity, Anxiety Disorders, Depression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity impacts mental health greatly. Psychological factors may influence the effectiveness of its treatment. This study aimed to compare symptoms of generalised anxiety disorder and depression among adult women across different weight categories. The study sample comprised 1105 adult women. The computer-assisted web interview (CAWI) utilising the seven-item Generalised Anxiety Disorders Scale (GAD-7) and the nine-item Patient Health Questionnaire (PHQ-9) was used. Both GAD-7 and PHQ-9 scores correlated positively with BMI (r = 0.121, p < 0.001 and r = 0.173, p < 0.001, respectively) and negatively with age (r = −0.106, p < 0.001 and r = −0.103, p < 0.001, respectively). Patients undergoing treatment with semaglutide scored lower for both anxiety symptoms (8.71 ± 6.16, p = 0.013) and depression symptoms (9.76 ± 6.37, p = 0.013). Women who underwent bariatric surgery screened less frequently for anxiety (8.03 ± 6.27, p = 0.002) but not for depression. An interdisciplinary approach involving mental health professionals within the therapeutic team can comprehensively address factors contributing to obesity development and treatment outcomes. Further investigation of semaglutide’s use is needed due to the promising evidence suggesting a positive effect on decreasing the severity of depression and anxiety symptoms to assess the direct or indirect character of this influence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityAnxiety DisordersDepressionHumansFemaleAdultMiddle AgedPolandAnti-Obesity AgentsGlucagon-Like PeptidesAnxietyPatient Health QuestionnaireYoung AdultBariatric SurgeryBody Mass IndexSurveys and QuestionnairesSemaglutide

Stichwörter der Autor:innen

BMIanxietydepressionobesitywomen health

Substanzen

Anti-Obesity AgentsGlucagon-Like PeptidesSemaglutide

Autor:innen und Institutionen

  • Tomasz Witaszek-Gabinet Leczenia Otyłości, ul. Józefińska 33/8, 30-529 Kraków, Poland.
  • MEDFIT Karolina Kłoda, ul. Narutowicza 13E/11, 70-240 Szczecin, Poland.
  • Department of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland.

ORCID-Profile: Tomasz Witaszek, Karolina Kłoda, Mateusz Babicki

Förderung

  • Wroclaw Medical University

Zitieren

APA

Witaszek, T., Kłoda, K., Mastalerz-Migas, A., & Babicki, M. (2024). Association between Symptoms of Depression and Generalised Anxiety Disorder Evaluated through PHQ-9 and GAD-7 and Anti-Obesity Treatment in Polish Adult Women. Nutrients. https://doi.org/10.3390/nu16152438

Vancouver

Witaszek T, Kłoda K, Mastalerz-Migas A, Babicki M. Association between Symptoms of Depression and Generalised Anxiety Disorder Evaluated through PHQ-9 and GAD-7 and Anti-Obesity Treatment in Polish Adult Women. Nutrients. 2024. doi:10.3390/nu16152438

BibTeX
@article{Witaszek2024,
  author = {Witaszek, Tomasz and Kłoda, Karolina and Mastalerz-Migas, Agnieszka and Babicki, Mateusz},
  title = {Association between Symptoms of Depression and Generalised Anxiety Disorder Evaluated through PHQ-9 and GAD-7 and Anti-Obesity Treatment in Polish Adult Women},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16152438}
}
Kostenlos starten →